bmy 7378 has been researched along with silodosin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
| Erami, C; Faber, JE; French, DM; Ho, JG; Zhang, H | 1 |
| Hiraizumi-Hiraoka, Y; Israilova, M; Kunitomo, M; Muramatsu, I; Shinozuka, K; Suzuki, F; Taki, N; Tanaka, T; Taniguchi, T; Zhang, L | 1 |
| Cotecchia, S; Hiroyama, M; Hosoda, C; Kitamura, T; Koike, K; Koshimizu, TA; Shibano, M; Tanaka, Y; Tanoue, A; Tsujimoto, G | 1 |
| Inada, Y; Kobayashi, K; Kobayashi, M; Kobayashi, S; Tadachi, M; Tomiyama, Y; Yamazaki, Y | 1 |
| Anisuzzaman, AS; Morishima, S; Muramatsu, I; Sathi, ZS; Suzuki, F; Tanaka, T; Yoshiki, H | 1 |
| Hoyano, Y; Itoh, Y; Kobayashi, S; Kohri, K; Kubota, Y; Kusama, H; Tomiyama, Y; Yamazaki, Y | 1 |
| Kobayashi, S; Kohri, K; Kojima, Y; Kubota, Y; Sasaki, S; Tomiyama, Y | 1 |
| Hirose, Y; Itoh, Y; Niimi, K | 1 |
| Li, MY; Tsai, KC; Xia, L | 1 |
| Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
2 review(s) available for bmy 7378 and silodosin
| Article | Year |
|---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
[Medical expulsive therapy facilitated by alpha 1 adrenoceptor antagonist].
Topics: Adrenergic alpha-1 Receptor Antagonists; Evidence-Based Medicine; Humans; Indoles; Meta-Analysis as Topic; Piperazines; Practice Guidelines as Topic; Receptors, Adrenergic, alpha-1; RNA, Messenger; Sulfonamides; Tamsulosin; Ureter; Urinary Calculi | 2011 |
9 other study(ies) available for bmy 7378 and silodosin
| Article | Year |
|---|---|
Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angioplasty, Balloon; Animals; Carotid Artery Injuries; Cell Division; Idazoxan; Imines; Indoles; Male; Muscle, Smooth, Vascular; Norepinephrine; Oxathiins; Piperazines; Piperidines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Recurrence; Tunica Intima; Vasoconstrictor Agents | 2002 |
Alpha-1D adrenoceptors are involved in reserpine-induced supersensitivity of rat tail artery.
Topics: Animals; Aorta, Thoracic; Arteries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Hypersensitivity; Gene Expression; Indoles; Japan; Male; Phenylephrine; Piperazines; Potassium Chloride; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Reserpine; RNA, Messenger; Serotonin; Spleen; Tail; Time Factors; Tritium | 2004 |
Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice.
Topics: Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Gene Expression Regulation; In Vitro Techniques; Indoles; Male; Mesenteric Arteries; Mice; Mice, Knockout; Norepinephrine; Piperazines; Prazosin; Receptors, Adrenergic, alpha-1; RNA, Messenger; Vasoconstriction | 2005 |
Expressions and mechanical functions of alpha1-adrenoceptor subtypes in hamster ureter.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Cricetinae; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression; Immunohistochemistry; In Vitro Techniques; Indoles; Male; Mesocricetus; Muscle Contraction; Muscle, Smooth; Norepinephrine; Phenylephrine; Piperazines; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ureter | 2007 |
Different affinities of native alpha1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Arteries; Binding, Competitive; Cell Line; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Humans; Indoles; Ketanserin; Male; Piperazines; Prazosin; Protein Binding; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Subcellular Fractions; Tail; Transfection; Vasoconstriction | 2008 |
Gene expressions and mechanical functions of α1-adrenoceptor subtypes in mouse ureter.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Epinephrine; Gene Expression; Indoles; Male; Mice; Mice, Inbred ICR; Muscle Contraction; Norepinephrine; Piperazines; Prazosin; Receptors, Adrenergic, alpha-1; RNA, Messenger; Ureter | 2009 |
Characterization of α1-adrenoceptor subtypes mediating contraction in human isolated ureters.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Indoles; Male; Middle Aged; Muscle Contraction; Piperazines; Prazosin; Receptors, Adrenergic, alpha-1; Ureter; Young Adult | 2011 |
Pharmacophore identification of alpha(1A)-adrenoceptor antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Evaluation, Preclinical; Expert Systems; Humans; Models, Molecular; Receptors, Adrenergic, alpha-1; Software; Structure-Activity Relationship | 2005 |
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |